1 / 7JP Morgan on ONGC | The brokerage sees material upside risks to consensus earnings estimates for ONGC. It maintained Overweight rating with a target price of Rs 190 per share.
2 / 7CLSA on Sun Pharmaceuticals | CLSA has a Buy call on Sun Pharma with a target of Rs 760 per share. It is of the view that significant operating leverage will accrue for the company over the coming years.
3 / 7JP Morgan on SAIL | JP Morgan expects the company's debt to reduce further and says that it is amongst the cheapest steel stock.
4 / 7Jefferies on Asian Paints | Jefferies initiated coverage on Asian Paints with a Buy call. It forecasts FY20-23 EPS cagr of 15 percent.
5 / 7Nomura on PNC Infratech | The brokerage maintains Buy rating on PNC Infra as it expects GAEPL deal to lead to the elimination of drag on parent cash flows.
6 / 7Credit Suisse on Consumer Sector | In the second COVID wave, the impact on consumption will differ from the first wave, says Credit Suisse. It believes there could be near-term headwinds for Avenue, UBBL & USL while Dabur, Tata Cons & Britannia may see gains.
7 / 7Credit Suisse on Steel Sector | Credit Suisse sees a large room for price hikes with Indian domestic prices now at 17%/11% discount to China/FTA imports.
